AGP Executive Report
Last update: 12 hours agoHealthcare Access & Waiting Times: A new OECD “Health at a Glance 2025” snapshot shows long waits for specialist care across Europe, with some countries seeing hip-replacement waits approaching two years—raising concerns about delayed treatment worsening outcomes. Poland Drug Policy 2.0: Poland is pushing “Drug Policy 2.0” after a record 1,211-day delay to new medicines, with oncology still a bright spot but reimbursement lag threatening patient access. New Medicine Trial (Autoimmune Skin Disease): JJP Biologics reports positive interim Phase 1b data for nebaprubart (JJP-1212), an anti-CD89 antagonist, in Linear IgA Disease, citing early safety and signs of faster symptom relief. Child Digital Health: Poland approved draft rules to ban mobile phones in primary schools from Sept. 1, 2026, alongside tighter age checks for porn sites—framing it as a child wellbeing and safety move. Tech Sovereignty in Public Sector: PM Donald Tusk says Poland will introduce a “sovereignty test” for major government tech purchases and publish annual IT independence reports, citing existential dependency risks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
